VEM PHARMACEUTICALS, founded in 2000, is a leading Turkish pharmaceutical company focused on delivering innovative healthcare solutions. Operating on a foundation of full Turkish ownership, the company embodies the synergy of scientific advancement and the robust production capabilities synonymous with Turkey.
With its headquarters in Turkey, VEM PHARMACEUTICALS boasts a cutting-edge manufacturing facility in Çerkezköy, complying with international standards while offering a wide array of forms, including solid, semi-solid, liquid, BFS, and injectables. The forthcoming facility in Lüleburgaz promises to elevate production capabilities with state-of-the-art technology and systems, enhancing their competitive edge on a regional level.
The company’s expansive reach includes over 270 national and 400 international marketing authorizations, serving over 50 countries. Their vast portfolio covers diverse therapeutic areas, meeting the evolving needs of global healthcare with a commitment embodying their slogan, "For a Healthier Future." Currently, there has been no recent investment declared. With a workforce of 1,700 colleagues, VEM PHARMACEUTICALS remains a trusted player in the pharmaceutical landscape, driven by a mission to fulfill both present and future societal health needs.